01 1Shilpa Medicare
01 1CABAZITAXEL
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-07-28
Pay. Date : 2020-07-02
DMF Number : 33087
Submission : 2020-06-30
Status : Active
Type : II
20
Shilpa Pharma Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CABAZITAXEL, with a corresponding US DMF Number 33087.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2020, and payment made on July 02, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
